These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Role of N-terminal residues in Aβ interactions with integrin receptor and cell surface. Venkatasubramaniam A; Drude A; Good T Biochim Biophys Acta; 2014 Oct; 1838(10):2568-77. PubMed ID: 24955499 [TBL] [Abstract][Full Text] [Related]
66. Inhibition of amyloid-β aggregation in Alzheimer's disease. Wang Q; Yu X; Li L; Zheng J Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775 [TBL] [Abstract][Full Text] [Related]
67. Combining intracellular selection with protein-fragment complementation to derive Aβ interacting peptides. Acerra N; Kad NM; Mason JM Protein Eng Des Sel; 2013 Jul; 26(7):463-70. PubMed ID: 23708321 [TBL] [Abstract][Full Text] [Related]
68. Amyloid beta-derived diffusible ligands (ADDLs) induce abnormal expression of insulin receptors in rat hippocampal neurons. Liu X; Teng Z; Cui C; Wang R; Liu M; Zhang Y J Mol Neurosci; 2014 Jan; 52(1):124-30. PubMed ID: 24402880 [TBL] [Abstract][Full Text] [Related]
69. Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. Townsend M; Mehta T; Selkoe DJ J Biol Chem; 2007 Nov; 282(46):33305-33312. PubMed ID: 17855343 [TBL] [Abstract][Full Text] [Related]
70. 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease. Shringarpure R; Grune T; Sitte N; Davies KJ Cell Mol Life Sci; 2000 Nov; 57(12):1802-9. PubMed ID: 11130184 [TBL] [Abstract][Full Text] [Related]
71. Alzheimer's amyloid-beta intermediates generated using polymer-nanodiscs. Sahoo BR; Genjo T; Bekier M; Cox SJ; Stoddard AK; Ivanova M; Yasuhara K; Fierke CA; Wang Y; Ramamoorthy A Chem Commun (Camb); 2018 Nov; 54(91):12883-12886. PubMed ID: 30379172 [TBL] [Abstract][Full Text] [Related]
72. Aβ Beyond the AD Pathology: Exploring the Structural Response of Membranes Exposed to Nascent Aβ Peptide. Rondelli V; Salmona M; Colombo L; Fragneto G; Fadda GC; Cantu' L; Del Favero E Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167440 [TBL] [Abstract][Full Text] [Related]
73. Insulin signaling in Huang Y; Wan Z; Wang Z; Zhou B Commun Biol; 2019; 2():13. PubMed ID: 30652125 [TBL] [Abstract][Full Text] [Related]
74. The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide. Boland K; Behrens M; Choi D; Manias K; Perlmutter DH J Biol Chem; 1996 Jul; 271(30):18032-44. PubMed ID: 8663372 [TBL] [Abstract][Full Text] [Related]
75. MicroRNA 7 Impairs Insulin Signaling and Regulates Aβ Levels through Posttranscriptional Regulation of the Insulin Receptor Substrate 2, Insulin Receptor, Insulin-Degrading Enzyme, and Liver X Receptor Pathway. Fernández-de Frutos M; Galán-Chilet I; Goedeke L; Kim B; Pardo-Marqués V; Pérez-García A; Herrero JI; Fernández-Hernando C; Kim J; Ramírez CM Mol Cell Biol; 2019 Nov; 39(22):. PubMed ID: 31501273 [TBL] [Abstract][Full Text] [Related]
76. A capillary electrophoresis method for evaluation of Abeta proteolysis in vitro. Alper BJ; Schmidt WK J Neurosci Methods; 2009 Mar; 178(1):40-5. PubMed ID: 19071160 [TBL] [Abstract][Full Text] [Related]
80. Comparison of the reaction of methylglyoxal (MGO) with murine and human amyloid beta (Aβ): Insights into a mechanism of Alzheimer's disease (AD). Shuster SO; Fica-Contreras SM; Hedges JS; Henning NJ; Choi S Biochem Biophys Res Commun; 2020 Dec; 533(4):1298-1302. PubMed ID: 33046246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]